HGG 12

Known as: HGG-12, Pyridinium, 1-(((3-benzoylpyridinio)methoxy)methyl)-2-((hydroxyimino)methyl)-, dichloride 
 

Topic mentions per year

Topic mentions per year

1979-1998
02419791998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The oximes HI-6, HLö-7, HGG-12, HGG-42 and obidoxime were used in a previously developed rat model to evaluate the therapeutic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1991
1991
Direct interactions of the bispyridinium oxime HGG-12 with muscarinic acetylcholine receptors were investigated in porcine… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1986
1986
A study of the effects of bisquaternary pyridinium oximes on calcium-dependent potassium-evoked [3H]acetylcholine release from… (More)
Is this relevant?
1985
1985
The mode of interaction of bisquaternary pyridinium oximes with rat brain muscarinic receptors in cerebral cortex and brain stem… (More)
Is this relevant?
1985
1985
The role of the functional substituents on the pyridinium ring of bisquaternary pyridinium compounds, mostly oximes, in exerting… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1984
1984
Acute sc toxicity of soman increased in the order, mice----rats----guinea pigs----dogs, being 12.6 times more toxic to dogs (LD50… (More)
Is this relevant?
1984
1984
It has been shown that HI-6 was the most potent oxime so far known in poisoning by sarin, VX , and soman, but its protective… (More)
Is this relevant?
1983
1983
Various oximes (PAM, toxogonin, TMB-4, HS-6, HI-6, HGG-12, HGG-42) combined with atropine were compared as antidotes of soman… (More)
Is this relevant?
1979
1979
Therapeutic properties of various combinations of the bispyridinium salts HGG-12 and HGG-42 against soman and sarin poisoning… (More)
Is this relevant?
1979
1979
Various doses of several bispyridinium compounds (HS-6, HI-6, HGG-12, HGG-42, and SAD-128) known to protect animals against the… (More)
Is this relevant?